SARS-CoV-2 B.1.351 vaccine (Pfizer/BioNTech)

N/A

Report date: 2026/01/23 11:09:03

Base Information

Drug NameSARS-CoV-2 B.1.351 vaccine (Pfizer/BioNTech)
Drug Alias NameSARS-CoV-2 variant-specific vaccine (Pfizer/BioNTECH)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioNTech US Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioNTech US IncPfizer IncBiontech Se
Active IndicationsN/A
Inactive IndicationsCoronavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A